Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis
Clinical trial NCT05018806 · COMPLETED
Trial details
- NCT number
- NCT05018806
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-09
- Primary completion
- 2023-06-23
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.